David B Preen
Overview
Explore the profile of David B Preen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
1623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soresi J, Bertilone C, Banks E, Marshall T, Murray K, Preen D
Health Informatics J
. 2025 Feb;
31(1):14604582251315414.
PMID: 39915942
Increasing digitisation in healthcare is flowing through to quality improvement strategies, like audit and feedback. To systematically review electronic audit and feedback (e-A&F) interventions in hospital settings, examining contemporary practices...
2.
Orr C, Sims S, Fisher C, ODonnell M, Glauert R, Preen D
Emerg Med Australas
. 2025 Jan;
37(1):e14557.
PMID: 39829419
Objective: To determine the association between family and domestic violence (FDV) exposure and ED attendance in Australian children. Methods: The present study comprised a population-based retrospective cohort study using deidentified...
3.
Nossent J, Keen H, Preen D, Inderjeeth C
J Rheumatol
. 2024 Dec;
52(3):219-225.
PMID: 39681370
Objective: Our aim was to compare the incidence of malignancy and its effect on mortality between hospitalized patients with rheumatoid arthritis (RA) and controls. Methods: We conducted a population-level observational...
4.
Taylor-Williams O, Keen H, Preen D, Nossent J, Inderjeeth C
Osteoporos Int
. 2024 Nov;
36(1):113-121.
PMID: 39532717
Background: Rheumatoid arthritis RA is a potentially devastating osteoimmunological disorder, predisposing to osteoporosis (OP), fragility fracture (FF), and major osteoporotic fractures (MOF). As few studies incorporate statistical matching, comorbidity and...
5.
Nossent J, Keen H, Preen D, Inderjeeth C
Int J Rheum Dis
. 2024 Oct;
27(10):e15379.
PMID: 39420796
Aim: To determine the incidence and health outcomes for juvenile idiopathic inflammatory myopathy (JIIM) in a long-term whole-population study. Methods: We included patients under 18 years hospitalized in Western Australia...
6.
Quintrell E, Page A, Wyrwoll C, Larcombe A, Preen D, Almeida O, et al.
Alcohol Alcohol
. 2024 Sep;
59(5).
PMID: 39242103
Aims: This study aimed to investigate acamprosate and naltrexone dispensing patterns in Australia. Methods: A 10% representative sample of medications subsidized by the Australian Pharmaceutical Benefits Scheme (PBS) was used...
7.
Kelty E, Murray K, Sanfilippo F, Preen D
Prehosp Emerg Care
. 2024 Aug;
:1-8.
PMID: 39212349
Objectives: The use of methoxyflurane is becoming increasingly popular in the treatment of pain in an emergency setting, in part due to its ease of administration. However, little is known...
8.
Feng Y, Li I, Kristoffersen I, Armstrong B, Preen D
Health Promot Int
. 2024 Aug;
39(4).
PMID: 39166485
This study examined changes in physical and mental health quality-of-life and health services access before and after the onset of the COVID-19 pandemic among individuals of lower and higher socio-economic...
9.
Almeida O, Etherton-Beer C, Sanfilippo F, Preen D, Page A
Aust N Z J Psychiatry
. 2024 Aug;
58(10):914-917.
PMID: 39129192
Objective: The objective of this study was to determine the proportion of Australians dispensed psychotropic medications between 2013 and 2022 according to their age. Methods: Services Australia provided a de-identified...
10.
Lopez D, Pritchard D, Sanfilippo F, Kelty E, Page A, Etherton-Beer C, et al.
Infect Dis Now
. 2024 Jul;
54(6):104953.
PMID: 38964717
Objectives: To compare the supply of molnupiravir and nirmatrelvir/ritonavir in relation to patient characteristics and other co-prescribed medicines and to estimate the number of patients without contraindications to nirmatrelvir/ritonavir who...